Drawing for KNOWING NOW MOVES US

USPTO serial 97560760

KNOWING NOW MOVES US

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
PHILLIPS, ALEXANDER J
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with KNOWING NOW MOVES US?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,442*

Plus Government fees of $1,200

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua S. Jarvis, Esq.

Joshua S. Jarvis, Esq. FOLEY HOAG LLP155 SEAPORT BOULEVARDBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
001Genetic testing kits for collecting biological samples comprised primarily of reagents and also including lancets, swabs for medical use, needles for medical purposes, collection tubes, dermal patches, and sample collection cards, all for collecting biological samples for laboratory use.ACTIVE—
005Genetic test kit comprised primarily of biological sample collection tools, namely, swabs for medical use, and also including devices in the nature of dermal patches for collecting biological samples, collection tubes, lancets, needles for medical purposes, and sample collection cards, all for collecting biological samples for use in performing genetic tests for medical diagnostic purposes; test kit for home or clinical use comprised primarily of biological sample collection tools, namely, swabs for medical use and also including lancets, needles for medical purposes, collection tubes, dermal patches for collecting biological samples, and sample collection cards, all for collecting biological samples for medical diagnostic testing; genetic test kits comprised primarily of biological sample collection tools, namely, swabs for medical use and also including devices in the nature of dermal patches for collecting biological samples, lancets, needles for medical use, biological sample collection tubes, and sample collection cards, all for collecting biological samples for use in performing medical genetic tests; vitamins; dietary supplements; nutritional supplements.ACTIVE—
009Downloadable mobile application software featuring instructions and instructional videos related to medical, genetic, and diagnostic tests; downloadable mobile application software featuring in-app purchases of digital and physical goods related to or derived from medical, genetic, and diagnostic tests and test results; downloadable mobile application software featuring in-app purchases of vitamins, dietary supplements, and nutritional supplements; downloadable reports for reporting the results of non-medical, medical, genetic and diagnostic tests; downloadable reports for reporting the results of non-medical, medical, genetic and diagnostic tests for medical, non-medical, genetic, health, wellness and fitness conditions; downloadable reports providing analyses and recommendations related to genetic testing and test results.ACTIVE—
010Test kits comprised of medical instruments for taking biological samples for review and testing for various non-medical, medical, and genetic conditions, namely, sample preparation devices for medical diagnostic use, medical diagnostic instruments for the analysis of body fluids, lancets, needles for medical use, medical swabs, dermal patches, sample collection cards, and collection tubes for taking biological samples for review and testing for various medical and genetic conditions; medical diagnostic testing kits consisting primarily of collection tools, namely, lancets, needles, medical swabs, collection tubes, dermal patches, and sample collection cards, and also including instructions and return shipping packaging, all for the collection of biological samples for use in testing, diagnosing and monitoring various medical and genetic conditions and diseases.ACTIVE—
035Online retail store services featuring medical, genetic and diagnostic tests and testing kits for collecting biological samples for personal, laboratory, scientific, and industrial use; online retail store services featuring cosmetics, foods, medical devices, and nutritional and weight loss products related to or derived from medical, genetic, and diagnostic tests and test results; online retail store services featuring digital goods in the nature of downloadable digital reports for reporting the results of non-medical, medical, genetic and diagnostic tests, downloadable digital reports providing analyses and recommendations related to genetic testing and test results, all related to or derived from medical, genetic, and diagnostic tests and test results; online retail store services featuring vitamins, dietary supplements, and nutritional supplements.ACTIVE—
040Custom manufacturing and custom synthesis of cells and DNA for scientific, research, and medical purposes.ACTIVE—
042Providing scientific analysis and scientific information regarding the results of laboratory and non-laboratory testing in the field of various non-medical, medical, genetic, health, wellness, and fitness related diseases and conditions; providing scientific analysis and scientific information regarding the results of testing in the field of various non-medical, medical, genetic, health, wellness, and fitness related diseases and conditions; providing medical research information regarding results of testing for various medical and genetic conditions and diseases; genetic testing of biological samples for scientific and medical research; providing temporary use of non-downloadable software for reporting the results of genetic tests and non-medical, medical and genetic diseases and conditions; providing non-medical research and scientific information in the fields of medicine, health, wellness and fitness; providing genetic testing in the fields of medicine, health, wellness and fitness for research purposes; software as a service (SAAS) services featuring software for reviewing, sharing, and analyzing results of medical, genetic, and diagnostic tests; software as a service (SAAS) services featuring software featuring instructions and instructional videos related to medical, genetic, and diagnostic tests; software as a service (SAAS) services featuring software that allows users to purchase digital and physical goods related to or derived from medical, genetic, and diagnostic tests and test results; software as a service (SAAS) services featuring software that allows users to purchase vitamins, dietary supplements, and nutritional supplements.ACTIVE—
044Medical, genetic and diagnostic testing and reporting services for medical purposes; medical testing services relating to the diagnosis and treatment of disease; medical, genetic and diagnostic testing of biological samples for treatment, identification, or monitoring of various medical and genetic diseases and conditions for medical purposes; medical, genetic and diagnostic testing of biological samples for treatment, identification, or monitoring of various medical and genetic diseases and conditions, namely, collecting and testing biological samples for medical purposes, providing laboratory and nonlaboratory medical and genetic testing for medical purposes, and medical and genetic information services, namely, reporting test results to customers, healthcare providers and patients for medical purposes; genetic testing of biological samples for medical purposes; medical testing of biological samples for diagnostic, informational, or monitoring purposes to provide users with personalized information for maintaining health and wellness; genetic testing of biological samples for medical diagnostic and treatment purposes; genetic testing of biological samples, namely, using biological samples for medical diagnostic and treatment purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 31, 2026EX4GSOU EXTENSION 4 GRANTED—
Aug 31, 2026EXT4SOU EXTENSION 4 FILED—
Aug 31, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2026EX3GSOU EXTENSION 3 GRANTED—
Feb 20, 2026EXT3SOU EXTENSION 3 FILED—
Feb 20, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 16, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 15, 2025EX2GSOU EXTENSION 2 GRANTED—
Aug 15, 2025EXT2SOU EXTENSION 2 FILED—
Aug 15, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Mar 10, 2025EXT1SOU EXTENSION 1 FILED—
Mar 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 28, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 28, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 28, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 28, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 24, 2024DOCKASSIGNED TO EXAMINER—
May 24, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 19, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 5, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 8, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 8, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 19, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 19, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 9, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 9, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 9, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 26, 2023DOCKASSIGNED TO EXAMINER—
May 12, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 12, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2022DOCKASSIGNED TO EXAMINER—
Aug 31, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 26, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance